#D-107 AAD 2024 - August 2025

Oral Minoxidil for Female Pattern Hair Loss

Dr. Victoria Turner, Dr. Andrew Phillips, Dr. Christine Evans, Dr. Paul Martinez
Therapeutic Area: Dermatology
Company: Pfizer
Study Type: Clinical Trial

Key Findings

Low-dose oral minoxidil increased hair density by 18% at 24 weeks. Patient satisfaction high with minimal side effects.

Summary

Low-dose oral minoxidil increased hair density by 18% at 24 weeks. Patient satisfaction high with minimal side effects.

Study Design

Open-label trial of oral minoxidil 0.25-2.5mg daily in 140 women with female pattern hair loss.

Methods

Dose escalation protocol based on response and tolerability. Hair counts and patient-reported outcomes assessed.

Results

Mean density increase 18% at 24 weeks, 28% at 48 weeks. Treatment satisfaction: 84%. Hypertrichosis: 15% (mild).

Conclusions

Low-dose oral minoxidil effective, well-tolerated treatment for female pattern hair loss with high patient satisfaction.

Full Abstract

This study examined oral minoxidil for female pattern hair loss in a comprehensive clinical investigation.